BioCryst Pharmaceuticals Inc. (BCRX) Drops 5.94% on February 02

Equities Staff |

BioCryst Pharmaceuticals Inc. (BCRX) was one of the Russell 2000's biggest losers for Tuesday February 02 as the stock slid 5.94% to $6.49, a loss of $-0.41 per share. Starting at an opening price of $6.80 a share, the stock traded between $6.44 and $6.85 over the course of the trading day. Volume was 573,710 shares over 4,274 trades, against an average daily volume of 861,605 shares and a total float of 73.34 million.

The losses send BioCryst Pharmaceuticals Inc. down to a market cap of $475.96 million. In the last year, BioCryst Pharmaceuticals Inc. has traded between $16.83 and $6.54, and its 50-day SMA is currently $9.32 and 200-day SMA is $11.28.

Biocryst Pharmaceuticals Inc is a biotechnology company. The Company designs, optimizes and develops novel small molecule drugs that block key enzymes involved in the pathogenesis of diseases.

BioCryst Pharmaceuticals Inc. is based out of Durham, NC and has some 50 employees. Its CEO is Jon P. Stonehouse.

For a complete fundamental analysis analysis of BioCryst Pharmaceuticals Inc., check out Equities.com’s Stock Valuation Analysis report for BCRX. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Lomiko Metals Inc.

Lomiko Metals Inc is an exploration stage company. It is engaged in the acquisition, exploration and development of resource properties. Its projects include Vines Lake project and Quatre - Milles…

Private Markets

Uber

Uber connects riders with safe, reliable, convenient transportation providers at a variety of price-points in cities around the world. Uber makes money from charging their drivers 20% of the fare…

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…